BioMed Realty Trust
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: San Diego, California, United States, North America
Region: California
Country: US
Continent: North America
About
BioMed Realty develops and operates purpose-built laboratory and office environments focused on life science and technology companies, with campuses across the United States and the United Kingdom. The company emphasizes resilient infrastructure and tenant-first service to support breakthrough science and research initiatives. Its properties are located in major biotech hubs, including the Bay Area, Boston/Cambridge, Boulder, San Diego, Seattle, and Cambridge, UK, among others. BioMed Realty positions itself as a premier operator of specialized life science real estate, integrating campuses that foster collaboration, innovation, and community. Headquarters are in San Diego, California.
BioMed Realty Trust develops and operates purpose-built laboratory and office environments for life science and technology companies. The company manages a portfolio of specialized real estate campuses in major innovation hubs across the United States and the United Kingdom, including Boston, San Francisco, and Cambridge, UK. Its focus is on providing resilient infrastructure and tenant-first serv
BioMed Realty Trust, Inc.
2004
for_profit
active
Industries
Primary Industry: Real Estate
Categories
Funding & Financials
Public Company
566000000
200m-1b
private
BMR
nasdaq
Founders
Gary A. Kreitzer
Leadership
Technology Stack
Products
Life Science Real Estate Properties: Leases and manages laboratory and office spaces tailored for life science companies across multiple U.S. and UK markets.
Integrated Life Science Campuses: Develops and manages large-scale, multi-phase campuses with laboratory and office facilities for life science tenants.
Property Management Services for Life Science Facilities: Provides property management and operational services for laboratory and office buildings serving life science tenants.
Funding rounds
Acquired · (2015-10-07)
IPO · (2004-08-13)
